GPT-6 Rosalind shows OpenAI now sells access, not just models, and European labs must govern it
i-SCOOP
Picture: i-SCOOP
OpenAI released GPT-6 Rosalind on 30 October 2026, its new model for biology and drug discovery. The headline fact sits in the system card: GPT-6 Rosalind uses the same weights as GPT-6 Astra, OpenAI’s general flagship, with no additional training data or post-training. What changes is the refusal boundary and who is allowed in. For European life sciences organisations, that turns the buying question around. You are not choosing a smarter model. You are applying for permission, and accepting obligations that your own governance has to carry. GPT-6 Rosalind is the third generation of GPT-Rosalind, the life sciences series OpenAI introduced in April. The product is called GPT-Rosalind-6 Research and the API model id is gpt-6-rosalind.
This report was first published by i-SCOOP. What you see here is a brief excerpt. The full text is theirs.
Continue reading at i-SCOOP
